| Drug Name (select from list of drugs shown) |
| Androgel (testosterone td gel) |
|
|
|
|
|
|
| Patient Information |
| Patient Name: |
|
|
| Patient ID: |
|
|
| Patient Group No.: |
|
|
| Patient DOB: |
|
|
| Prescribing Physician |
| Physician Name: |
|
|
| Physician Phone: |
|
|
| Physician Fax: |
|
|
| Physician Address: |
|
|
| City, State, Zip: |
|
|
| Please circle the appropriate answer for each question. |
| |
[If the answer to this question is no, then no further questions are required.] |
|
| 2. |
Does the patient have confirmed or suspected carcinoma of the prostate or breast? |
|
|
| 3. |
Is the patient being treated for primary hypogonadism (congenital or acquired)? |
|
|
| |
[If the answer to this question is yes, then skip to question 5.] |
|
| 4. |
Is the patient being treated for secondary (i.e. hypogonadotropic) hypogonadism (e.g., idiopathic gonadotropin or LHRH deficiency)? |
|
|
| |
[If the answer to this question is no, then no further questions are required.] |
|
| 5. |
Before the start of testosterone therapy did the patient (or does the patient currently) have a confirmed low testosterone level (i.e. morning total testosterone less than 300 ng/dL, morning free or bioavailable testosterone morning free or bioavailable testosterone less than 5 ng/dL) or absence of endogenous testosterone? |
|
|
I affirm that the information given on this form is true and accurate as of this date.
|